Kathryn MacFarlane

Dr. Kathryn MacFarlane is a Managing Partner & Owner at SmartPharma LLC and a Senior Vice President-Commercial Development at Napo Pharmaceuticals, Inc. She is on the Board of Directors at Neurizon Therapeutics Ltd. Dr. MacFarlane was previously employed as a Non-Executive Director by Mayne Pharma Group Ltd., an Independent Director by RespireRx Pharmaceuticals, Inc., a Chief Commercial Officer by Agile Therapeutics, Inc., a President & Chief Executive Officer by Xintria Pharmaceutical Corp., a Co-EVP-Commercial Operations by Jaguar Health, Inc., a Senior Director-Marketing by Parke-Davis Pharmaceutical Research, Inc., a VP-Sales, Marketing & New Product Planning by Pfizer Inc., a VP-Sales, Marketing & New Products by Warner Chilcott, Inc., and a Senior Director-Marketing by Warner-Lambert Co. She also served on the board at INMED Partnerships For Children.
She received her undergraduate degree from Purdue University and a doctorate degree from Purdue University.